Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	518.24	-119.20	19.28
Graham Fair Price	-24.07	0.37	0.48
PEG	182.70	-0.14	0.05
Price/Book	64.47	-14.15	-39.82
Price/Cash Flow	-269.20	-41.25	-11.17
Prices/Earnings	-269.85	-10.45	-2.83
Price/Sales	131.31	15.78	6.82
Price/FCF	-269.20	-41.25	-11.17
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-67.89	0.01	-0.04
Operating Margin	-7.70	-0.56	-0.52
ROA	75.35	< 0.005	-0.03
ROE	3.52	0.34	-90.39
ROIC	-0.07	-0.02	74.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	96.57
Dividends QOQ	-0.75	-0.60	19.21
EBIT QOQ	-0.81	0.58	-28.22
EPS QOQ	-0.58	0.76	30.83
FCF QOQ	-0.57	0.76	33.16
Revenue QOQ	0.19	-0.61	224.03
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	642.82	1730.89	169.26
Days Sales Outstanding (DSO)	1063.35	2643.80	148.63
Inventory Turnover	0.14	0.05	-62.86
Debt/Capitalization	1.03	1.08	4.52
Quick Ratio	0.19	0.19	-4.67
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-0.05	-0.13	-144.98
Cash	0.04	0.03	-25.03
Capex	< 0.005	< 0.005	72.85
Free Cash Flow	-0.19	-0.05	76.43
Revenue	0.32	0.12	-62.37
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.67	0.66	-2.28
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.01	-59.38	558.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating